Influence of Somesthesic Input on Subjective Visual Vertical in Dyslexic Children

Author(s):  
Nathalie Goulème ◽  
Philippe Villeneuve ◽  
Christophe-Loïc Gérard ◽  
Hugo Peyre ◽  
Maria Pia Bucci

Purpose: We explored the perception of subjective visual vertical (SVV) in dyslexic and non-dyslexic age, sex and QImatched.Method: The SVV was evaluated with a laser and with or without foam under the feet. We performed an analysis ofvariance. Post hoc comparisons were made with the Fisher’s least significant differences test (LSD).Results: Our results showed two significant effects for groups and for tilt condition: counterclockwise or clockwisedirection and a significant interaction between group, tilt and somesthesic condition: without and with foam underthe feet. More precisely, SVV response in the tilt counterclockwise condition with foam was found to be significantlyless accurate for the dyslexic group than for the non-dyslexic group. Also, SVV response in the tilt counterclockwisedirection was found to be significantly less accurate for both groups compared to clockwise direction. Moreover, inclockwise direction SVV process was found to be significantly less accurate in dyslexic than in non-dyslexic group.Conclusion: These results suggest that the somesthesic information from foot sole affect SVV perception; such poorSVV responses could be due to an immaturity for heteromodal sensory integration needed in SVV perception.

Neurology ◽  
2014 ◽  
Vol 82 (22) ◽  
pp. 1968-1975 ◽  
Author(s):  
T.-H. Yang ◽  
S.-Y. Oh ◽  
K. Kwak ◽  
J.-M. Lee ◽  
B.-S. Shin ◽  
...  

2011 ◽  
Vol 69 (3) ◽  
pp. 509-512 ◽  
Author(s):  
Martha Funabashi ◽  
Natya N.L. Silva ◽  
Luciana M. Watanabe ◽  
Taiza E.G Santos-Pontelli ◽  
José Fernando Colafêmina ◽  
...  

Subjective visual vertical (SVV) evaluates the individual's capacity to determine the vertical orientation. Using a neck brace (NB) allow volunteers' heads fixation to reduce cephalic tilt during the exam, preventing compensatory ocular torsion and erroneous influence on SVV result. OBJECTIVE: To analyze the influence of somatosensory inputs caused by a NB on the SVV. METHOD: Thirty healthy volunteers performed static and dynamic SVV: six measures with and six without the NB. RESULTS: The mean values for static SVV were -0.075º±1.15º without NB and -0.372º±1.21º with NB. For dynamic SVV in clockwise direction were 1.73º±2.31º without NB and 1.53º±1.80º with NB. For dynamic SVV in counterclockwise direction was -1.50º±2.44º without NB and -1.11º±2.46º with NB. Differences between measurements with and without the NB were not statistically significant. CONCLUSION: Although the neck has many sensory receptors, the use of a NB does not provide sufficient afferent input to change healthy subjects' perception of visual verticality.


2018 ◽  
Vol 24 (1) ◽  
pp. e1757 ◽  
Author(s):  
Brooke N. Klatt ◽  
Patrick J. Sparto ◽  
Lauren Terhorst ◽  
Stanley Winser ◽  
Rock Heyman ◽  
...  

2009 ◽  
Vol 129 (1) ◽  
pp. 30-35 ◽  
Author(s):  
Masayuki Asai ◽  
Mitsuhiro Aoki ◽  
Hisamitsu Hayashi ◽  
Nansei Yamada ◽  
Keisuke Mizuta ◽  
...  

2010 ◽  
Vol 01 (01) ◽  
Author(s):  
Fumiyuki Goto ◽  
Tomoko Tsutumi ◽  
Hironari Kobayashi ◽  
Akira Saito ◽  
Jin Kanzaki

2009 ◽  
Vol 267 (3) ◽  
pp. 357-361 ◽  
Author(s):  
Seok Min Hong ◽  
Seung Geun Yeo ◽  
Jae Yong Byun ◽  
Moon Suh Park ◽  
Chan Hum Park ◽  
...  

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Salman Waheed ◽  
Simcha Pollack ◽  
Marguerite Roth ◽  
Nathaniel Reichek ◽  
Alan Guerci ◽  
...  

Objective: Coronary artery calcium score (CAC) predicts cardiovascular (CV) risk independent of conventional risk profile. However, it remains unclear how clinical risk profile modifies CV outcomes among subjects with elevated CAC with and without lipid lowering therapy. Methods: We conducted a post hoc analysis of the treatment trial of the St. Francis Heart Study_double-blind, placebo-controlled randomized clinical trial of atorvastatin 20 mg, vitamin C 1 g, and vitamin E 1,000 U daily, versus matching placebos in 993 asymptomatic individuals with CAC at or above the 80th percentile for age and gender. Primary CV outcomes included non-fatal MI or coronary death, coronary revascularization, stroke, and peripheral arterial revascularization. Among the placebo and treatment groups, we further stratified by eligibility for statin therapy based on current AHA guidelines yielding 4 subgroups: treated not eligible (+Rx/-E), placebo not eligible (-Rx/-E), treated eligible (+Rx/+E) and placebo eligible (-Rx/+E). Results: Mean age was 59±6 years. Those eligible were older (61±5 vs. 56±5 years) and more likely to be males (85% vs. 56%) than those not eligible. Median [IQR] CAC was higher in the eligible than not eligible groups (overall, p<0.0001), 199 [112-396] (+Rx/-E), 207 [114-416] (-Rx/-E), 490 [289-791] (+Rx/+E) and 484 [286-837] (-Rx/+E). After a median follow up of 4.8 years, 4.0%, 4.8%, 9.8% and 15.4% had a CV event in +Rx/-E, -Rx/-E, +Rx/+E and -Rx/+E, respectively. After adjusting for CV risk factors and CAC, hazard ratio (95% CI) was 1.1 (0.4-2.9), 3.3 (1.1-9.4) and 4.9 (1.7-14.0) for -Rx/-E, +Rx/+E and -Rx/+E, respectively compared to +Rx/-E. There was a significant interaction between CAC and eligibility for statin therapy for a CV outcome (p=0.05). Conclusion: Among subjects with elevated CAC, those eligible for statin therapy have higher CAC and overall greater risk for a CV outcome than those not eligible. While statin therapy lowers CV risk among those eligible, it does not significantly alter CV risk among those not eligible. There is a significant interaction between CAC and statin therapy eligibility for a CV outcome. Our findings suggest that clinical risk profile remains an important risk modifier for CV outcomes among those with elevated CAC.


Sign in / Sign up

Export Citation Format

Share Document